New zap-and-heal catheter aims to fix irregular heartbeat without long-term drugs

NCT ID NCT06696170

Recruiting now Disease control Sponsor: Pulse Biosciences, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called the CellFX Nano-PFA 360 catheter, which uses very short electrical pulses to treat atrial fibrillation (an irregular heartbeat). About 60 adults aged 18 to 75 with paroxysmal atrial fibrillation will receive this procedure. The goal is to see if it is safe and can restore normal heart rhythm by blocking faulty electrical signals in the heart.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (PAROXYSMAL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac atrial fibrillation paroxysmal atrial fibrillation ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (PAROXYSMAL) CARDIAC ABLATION CARDIAC ARRHYTHMIA

Contacts and locations

Locations

Hartcentrum Hasselt Research Center /Jessa Hospital
ACTIVE_NOT_RECRUITING

Hasselt, Belgium
Na Homolce Hospital
RECRUITING

Prague, Czechia
Policlinico Tor Vergata Hospital
RECRUITING

Roma, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.